The Gadoteridol Injection, cataloged under National Stock Number 6505-01-371-4206, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bracco Diagnostics Inc.. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-371-4206 |
| Primary Part Number | NDC00270-1111-03 |
| Item Name | Gadoteridol Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bracco Diagnostics Inc. |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00270-1111-03 PRIMARY | Bracco Diagnostics Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00270-1111-03 | 3/9 Design control — primary reference Squibb E R and Sons Inc World Hq |
| PROHANCE | 5/9 Secondary reference Squibb E R and Sons Inc World Hq |
| NDC00003-1111-03 | 5/9 Secondary reference Squibb E R and Sons Inc World Hq |
NSN 6505-01-371-4206 is a Gadoteridol Injection, manufactured by Bracco Diagnostics Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-371-4206 has 1 manufacturer part number on file: NDC00270-1111-03 (Bracco Diagnostics Inc.).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-375-7541. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00270-1111-03: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: EACH ML CONTAINS 279.3 MG GADOTERIDOL, 0.23 MG CALTERIDOL CALCIUM, 1.21 MG TROMETHAMINE AND WATER FOR INJECTION; 20-ML FILLS IN SINGLE 30 ML VIAL; NON-IONIC CONTRAST MEDIUM FOR MAGNETIC RESONANCE IMAGING (MRI); 5 PER PACKAGE; Part Name Assigned by Controlling Agency: GADOTERIDOL INJECTION USP 30ML VIAL 5S. 1 specification is documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.